Impact of nutrition intervention-oriented prospective nursing for patients with advanced breast cancer

doi:10.3760/cma.j.issn.1007-1245.2023.11.028

Abstract

Abstract:

Objective　To analyze the effect of nutrition intervention-oriented prospective nursing for patients with advanced breast cancer treated by chemotherapy combined with disulfiram. Methods　This study was a randomized controlled trial. A total of 80 patients with advanced breast cancer who received chemotherapy combined with disulfiram in The First Affiliated Hospital of Henan University from June 2019 to May 2022 were prospectively selected and were divided into two groups according to the random number table method. The control group was (52.16±8.27) years old; the pathological types included 36 cases of invasive ductal carcinoma and 4 cases of invasive lobular carcinoma; there were 16 cases of menopause and 24 cases of premenopause; the molecular subtypes included 23 cases of Luminal type, 13 cases of triple-negative type, and 4 cases of human epidermal growth factor receptor-2 (Her-2) overexpression type. The observation group was (53.05±7.29) years old; the pathological types included 34 cases of invasive ductal carcinoma and 6 cases of invasive lobular carcinoma; there were 18 cases of menopause and 22 cases of premenopause; the molecular subtypes included 22 cases of Luminal type, 15 cases of triple-negative type, and 3 cases of Her-2 overexpression type. The control group received routine nursing intervention, and the observation group received nutrition intervention-oriented prospective nursing intervention on the basis of the control group. The two groups were compared in terms of nutritional status and immune function [peripheral blood immunoglobulin A (IgA), IgM, IgG, and T-lymphocyte subsets (CD₃⁺, CD₄⁺, and CD₄⁺/CD₈⁺)] and quality of life [Functional Assessment of Cancer Therapy-Breast (FACT-B)] before and after intervention. Statistical methods used were χ² test, t test, and u test. Results　The rate of good nutrition in the observation group was higher than that in the control group [70.00% (28/40) vs. 55.00% (22/40)] (u=2.240, P<0.05). After intervention, the levels of CD₃⁺, CD₄⁺, CD₄⁺/CD₈⁺, and serum IgA, IgM, and IgG in the observation group were higher than those in the control group [(50.12±3.88) vs. (39.76±4.04), (37.22±3.51) vs. (30.64±2.99), (1.41±0.15) vs. (1.29±0.18), (2.14±0.31) g/L vs. (1.85±0.27) g/L, (1.94±0.33) g/L vs. (1.36±0.28) g/L, (11.62±3.50) g/L vs. (10.07±2.84) g/L], with statistically significant differences (t=11.697, 9.026, 3.239, 4.462, 8.476, and 2.175; all P<0.05). After intervention, the scores of emotional status, physiological status, functional status, social and family status, and additional attention in the observation group were higher than those in the control group [(20.15±3.07) points vs. (16.14±2.58) points, (22.13±3.85) points vs. (17.69±3.24) points, (22.64±3.59) points vs. (17.83±3.12) points, (20.36±4.58) points vs. (17.14±4.09) points, (27.12±7.39) points vs. (20.45±6.80) points], with statistically significant differences (t=6.324, 5.581, 6.396, 3.317, and 4.201; all P<0.05). Conclusion　Nutrition intervention-oriented prospective nursing can improve the nutritional status, immune function, and quality of life in patients with advanced breast cancer treated by chemotherapy combined with disulfiram.

Key words:

Advanced breast cancer, Chemotherapy, Disulfiram, Immune function, Nutrition, Prospective nursing

摘要：

目的　分析以营养干预为导向的前瞻性护理对化疗联合双硫仑治疗的晚期乳腺癌患者的影响。方法　本研究为随机对照试验。前瞻性选取2019年6月至2022年5月河南大学第一附属医院80例晚期乳腺癌患者，均接受化疗联合双硫仑治疗，根据随机数字表法分为两组，每组40例。对照组年龄（52.16±8.27）岁，病理类型：浸润性导管癌36例、浸润性小叶癌4例，月经状态：绝经16例、未绝经24例，分子亚型：Luminal型23例、三阴性13例、人表皮生长因子受体-2（Her-2）过表达型4例，接受常规护理干预。观察组年龄（53.05±7.29）岁，病理类型：浸润性导管癌34例、浸润性小叶癌6例，月经状态：绝经18例、未绝经22例，分子亚型：Luminal型22例、三阴性15例、Her-2过表达型3例，在对照组基础上接受以营养干预为导向的前瞻性护理干预。比较两组营养状态、干预前后免疫功能［外周血免疫球蛋白A（immunoglobulin A，IgA）、IgM、IgG，T淋巴细胞亚群（CD₃⁺、CD₄⁺、CD₄⁺/CD₈⁺）］、生活质量［乳腺癌患者生存质量量表（FACT-B）］。统计学方法采用χ²检验、t检验、u检验。结果　观察组营养良好率高于对照组［70.00%（28/40）比55.00%（22/40）］（u=2.240，P<0.05）；干预后，观察组CD₃⁺、CD₄⁺、CD₄⁺/CD₈⁺、血清IgA、IgM、IgG水平均高于对照组［（50.12±3.88）比（39.76±4.04）、（37.22±3.51）比（30.64±2.99）、（1.41±0.15）比（1.29±0.18）、（2.14±0.31）g/L比（1.85±0.27）g/L、（1.94±0.33）g/L比（1.36±0.28）g/L、（11.62±3.50）g/L比（10.07±2.84）g/L］，差异均有统计学意义（t=11.697、9.026、3.239、4.462、8.476、2.175，均P<0.05）；干预后，观察组情感状况、生理状况、功能状况、社会家庭状况、附加关注评分均高于对照组［（20.15±3.07）分比（16.14±2.58）分、（22.13±3.85）分比（17.69±3.24）分、（22.64±3.59）分比（17.83±3.12）分、（20.36±4.58）分比（17.14±4.09）分、（27.12±7.39）分比（20.45±6.80）分］，差异均有统计学意义（t=6.324、5.581、6.396、3.317、4.201，均P<0.05）。结论　以营养干预为导向的前瞻性护理应用于化疗联合双硫仑治疗的晚期乳腺癌患者，可改善其营养状态、免疫功能，提高生活质量。

关键词:

晚期乳腺癌, 化疗, 双硫仑, 免疫功能, 营养, 前瞻性护理

Tian Ruiting, He Jianxin.

Impact of nutrition intervention-oriented prospective nursing for patients with advanced breast cancer [J]. International Medicine and Health Guidance News, 2023, 29(11): 1599-1603.

田瑞婷何建鑫.

营养干预导向的前瞻性护理对晚期乳腺癌患者的影响 [J]. 国际医药卫生导报, 2023, 29(11): 1599-1603.

References

[1] 桑蝶,宋丽华,邸立军,等.艾立布林治疗晚期乳腺癌疗效和安全性的多中心真实世界研究[J].中华肿瘤杂志,2022,44(4):364-369. DOI:10.3760/cma.j.cn112152-20210226- 00173.
[2] 徐鸣,王秋梅,范芳琴,等.4CR模式对乳腺癌化疗患者自我感受、情绪和生活质量的影响[J].检验医学与临床,2022,19(7):958-961. DOI:10.3969/j.issn.1672-9455.2022. 07.026.
[3] 林红霞,戴正银,韩秀芹.叙事性心理治疗联合正念减压改善乳腺癌化疗患者睡眠与生活质量的应用价值[J].河北医药,2022,44(14):2175-2178. DOI:10.3969/j.issn.1002- 7386.2022.14.022.
[4] 黄小妹,吴宏,李嘉雯,等.营养干预对局部晚期鼻咽癌患者放化疗期体质量及营养状态的影响[J].现代生物医学进展,2020,20(12):2317-2320,2324. DOI:10.13241/j.cnki.pmb.2020.12.025.
[5] 彭姗姗,吕俭霞,周秋琴,等.PG-SGA主导的营养干预对鼻咽癌放化疗患者的效果评价[J].徐州医科大学学报,2022,42(5):326-329. DOI:10.3969/j.issn.2096-3882.2022. 05.003.
[6] 吉润芷,王艳,王鹿婷,等.前瞻性护理在高血压性脑出血偏瘫病人中的应用[J].中国临床神经外科杂志,2020,25(9):635-636. DOI:10.13798/j.issn.1009-153X.2020.09.022.
[7] 侯小红,张悦.前瞻性护理对脑卒中偏瘫患者下肢深静脉血栓形成发生率的影响[J].血栓与止血学,2020,26(4):708-709. DOI:10.3969/j.issn.1009-6213.2020.04.069.
[8] Thill M, Liedtke C, Müller V, et al. AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2018[J]. Breast Care (Basel), 2018, 13(3):209-215. DOI: 10.1159/000489331.
[9] 陈冰清,黄少容,许晓丹,等.NRS-2002用于食管癌住院患者营养风险筛查的效果研究[J].国际医药卫生导报,2021,27(16):2460-2463. DOI:10.3760/cma.j.issn.1007-1245. 2021.16.008.
[10] 李楠楠,王静,马亚松,等.基于智谋理论的临床干预对乳腺癌术后化疗患者营养状态、不良反应和疾病获益感的影响[J].癌症进展,2022,20(11):1137-1140. DOI:10.11877/j.issn.1672-1535.2022.20.11.14.
[11] 邢舒,汪红英,颜清,等.多渠道自我管理模式的构建对乳腺癌术后化疗患者生活质量的影响[J].中华保健医学杂志,2021,23(1):57-60. DOI:10.3969/j.issn.1674-3245.2021. 01.016.
[12] 陈洁,陈秀华.乳腺癌PICC化疗应用配偶赋能认知教育的效果及对不良情绪、FACT-B评分的影响[J].河北医药,2022,44(4):581-584. DOI:10.3969/j.issn.1002-7386. 2022.04.026.
[13] 谢莹莹.以家庭为中心的护理干预在VPA乳腺癌化疗患者的应用效果[J].国际医药卫生导报,2022,28(17):2504-2507. DOI:10.3760/cma.j.issn.1007-1245.2022. 17.031.
[14] 黄世芬,燕冰雪,夏云霞,等.阿帕替尼联合化疗治疗晚期乳腺癌的临床研究[J].兰州大学学报(医学版),2021,47(1):52-58. DOI:10.13885/j.issn.1000-2812.2021.01.009.
[15] 郭向阳,梁帅,李嘉,等.乌苯美司治疗乳腺癌放化疗后免疫功能低下患者的疗效观察[J].山西医药杂志,2021,50(5):703-705. DOI:10.3969/j.issn.0253-9926.2021.05.001.
[16] 赵芳,韩丽娟,杜一虹.乳腺癌术后辅助化疗患者营养风险评价及其对患者生活质量和化疗不良反应的影响[J].中国妇幼保健,2021,36(23):5424-5426. DOI:10.19829/j.zgfybj.issn.1001-4411.2021.23.019.
[17] 万毅,姚永强,解继平,等.肠内营养对乳腺癌术后化疗患者肠道菌群及生活质量的影响[J].中国微生态学杂志,2020,32(10):1157-1161. DOI:10.13381/j.cnki.cjm.202010010.
[18] De Cicco P, Catani MV, Gasperi V, et al. Nutrition and breast cancer: a literature review on prevention, treatment and recurrence[J]. Nutrients, 2019, 11(7):1514. DOI: 10.3390/nu11071514.
[19] Dunneram Y, Greenwood DC, Cade JE. Diet, menopause and the risk of ovarian, endometrial and breast cancer[J]. Proc Nutr Soc, 2019, 78(3):438-448. DOI: 10.1017/S0029665118002884.
[20] 余嘉文,程进,姚文娟,等.规范化营养干预下食管癌患者放化疗营养状况分析[J].重庆医学,2022,51(11):1841-1845,1851. DOI:10.3969/j.issn.1671-8348.2022.11.008.
[21] 苗静,吴瑾,秦叔逵,等.全优膳用于恶性肿瘤患者营养支持的前瞻性、开放标签、非干预性、多中心的临床观察性研究报告[J].临床肿瘤学杂志,2020,25(9):769-775. DOI:10.3969/j.issn.1009-0460.2020.09.001.
[22] 王玲艳,冯霞.追踪管理模式对乳腺癌放疗患者心理状态及营养状况的影响[J].中国健康心理学杂志,2021,29(1):58-62. DOI:10.13342/j.cnki.cjhp.2021.01.011.
[23] 苗培田,佟仲生,鲍双振.DC-CIK联合FAC化疗方案治疗乳腺癌的疗效及对患者免疫功能和肿瘤标志物水平的影响[J].中国妇幼保健,2021,36(9):2011-2015. DOI:10.19829/j.zgfybj.issn.1001-4411.2021.09.019.
[24] 张超,王晓林,李晨辉,等.肿瘤与免疫细胞通过外泌体相互作用的研究进展[J].肿瘤学杂志,2020,26(6):469-474. DOI:10.11735/j.issn.1671-170X.2020.06.B001.
[25] 程曦,黄凝,李鸿泉,等.枸杞多糖通过调节免疫在肿瘤免疫治疗中的应用前景分析[J].中医药学报,2022,50(2):1-4. DOI:10.19664/j.cnki.1002-2392.220026.
[26] 胡想金,高耀,闾军.恒定的自然杀伤T淋巴细胞在肝脏抗肿瘤免疫中的作用与机制[J].临床肝胆病杂志,2021,37(1):188-191. DOI:10.3969/j.issn.1001-5256.2021.01.041.
[27] 黄克华,张健,于勇.晚期乳腺癌患者新辅助化疗前后T淋巴细胞亚群变化及与临床疗效的关系[J].热带医学杂志,2022,22(1):111-114. DOI:10.3969/j.issn.1672-3619. 2022.01.025.
[28] 尤校雷,徐辉,谷峪,等.舒芬太尼静脉自控镇痛对腹腔镜肾癌根治术患者镇痛效果、免疫功能和应激反应的影响[J].现代中西医结合杂志,2021,30(14):1560-1563,1567. DOI:10.3969/j.issn.1008-8849.2021.14.018.
[29] 刘艳红.基于营养风险筛查下营养支持对胃癌根治术患者的预后效果[J].国际医药卫生导报,2019,25(21):3647-3649. DOI:10.3760/cma.j.issn.1007-1245.2019. 21.049.